Sustained release matrix pharmaceutical composition
作者： Amit Mukharya , Abhaykumar Chandak , Anandi Krishnan
DOI:
关键词:
摘要: A sustained release pharmaceutical composition in solid dosage form is provided comprising (a) a therapeutically effective amount of one or more active agents; (b) first high viscosity retarding cellulose ether; and (c) second ether, wherein the ethers are same material.
lens.org 参考文章(8)
Chung Yuen Lui, Sustained release with high and low viscosity HPMC ,(1991)
Phillip Nixon, Joseph Fleishaker, Mark Eller, Robert Franz, Leo Lucisano, Sustained-release alprazolam composition ,(2003)
Chih-Ming Chen, Der-Yang Lee, Delayed pulse release hydrogel matrix tablet ,(1994)
Jr. Jackson B. Hester, 8-Chloro-1-methyl-6-(O-chlorophenyl)-4H-s-triazolo[4,3-a]-[1,4]benzodiazepine compositions and method of treatment ,(1972)
Judy A. Magruder, Gurdish Kaur Bhatti, David Emil Edgren, Controlled-release oral dosage forms comprising different cellulose ethers ,(1989)
Jr Jackson B Hester, Process for the production of 6-phenyl-4-H-s-triazolo {8 4,3-a{9 {8 1,4{9 benzodiazepines ,(1974)
Hester Jackson Boling, 6-PHENYL-4H-S-TRIAZOLO(4,3-A)+8 1,4)BENZODIAZEPINES ,(1972)